Doing the Right Right Thing, and Doing it Better: A Life Sciences Primer on ESG
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
Francesco de Rubertis, a co-founder of Medicixi Ventures, has unveiled the next generation of the venture-backed asset-centric biopharma model with the creation of Centessa Pharmaceuticals Ltd. The new company was created by acquiring, in all-share transactions, total control of 10 companies from the Medicxi portfolio. Read more at BioWorld.com
2021: Priorities for European Pharma & What does the investment landscape look like post Covid-19?
This year, in collaboration with Dechert, we held a virtual version of our leading Annual Healthcare Investor Conference on the 8th of October. The 12th event discussed how life sciences innovation is driving change – from the myriad international efforts against Covid-19 to how we communicate with the investment community. The virtue of virtual was […]
– Future of healthcare conference in partnership with Dechert LLP goes virtual – Panellists include eminent leaders from healthcare industry and investment community LONDON, Oct. 5, 2020 /PRNewswire/ — Optimum Strategic Communications (Optimum), the international strategic healthcare communications firm, will be hosting its 12th Annual Healthcare Investor Conference virtually, in partnership with Dechert LLP, on Thursday, 8 October 2020. In an unprecedented time for […]